Royfman R
No ORCID on file
· 1 paper in corpus
· active 2021
While ovarian cancer typically responds well to front line treatment, many patients will relapse within 5 years. Treatment options are less effective at each recurrence highlighting the need for novel maintenance therapies. PolyADP-ribose p…